Fig. 3From: Epilepsy control with carbamazepine monotherapy from a genetic perspectiveCarbamazepine plasma levels Vs genotypes at 3rd month and 6th month of the therapy. One Way ANOVA followed by Tukey’s test was used to compare the plasma level of carbamazepine among different genotypes of MTHFR (C677T and A1298C) gene polymorphismsBack to article page